Eradication of Helicobacter pylori in hemodialysis patients

Renal Failure

Volumn 29, Issue 1, 2007, Pages 97-102

  Itatsu, Tomoko ^a   Miwa, Hiroto ^b   Nagahara, Akihito ^c   Kubota, Minoru ^d   Miyazaki, Akihisa ^a   Sato, Nobuhiro ^c   Hayashida, Yasuo ^c  

^a Juntendo University Hospital   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Oji Hospital   (Japan)

Author keywords

Hemodialysis; LAC regimen; LC regimen

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; UREASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DIGESTIVE TRACT ENDOSCOPY; DRUG SAFETY; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMODIALYSIS; HEMODIALYSIS PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TASTE DISORDER; TREATMENT OUTCOME; UPPER GASTROINTESTINAL TRACT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 33846999697     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220601039122     Document Type: Article

References (36)

1. Milito G, Taccone-Gallucci M, Brancaleone C, et al. The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int Suppl. 1985;17:157-160.
2. Ala-Kaila K. Upper gastrointestinal findings in chronic renal failure. Scand J Gastroenterol. 1987;22:372-376.
3. Chalasani N, Cotsonis G, Wilcox CM. Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol. 1996;91:2329-2332.
4. Chachati A, Godon JP. Effect of hemodialysis on upper gastrointestinal tract pathology in patients with chronic renal failure. Nephrol Dial Transplant. 1987;1:233-237.
5. Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz E. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther. 2004;19:617-629.
6. Holtmann G, Howden CW. Review article: management of peptic ulcer bleeding - the roles of proton pump inhibitors and Helicobacter pylori eradication. Aliment Pharmacol Ther. 2004;19:66-70.
7. Tamura H, Tokushima H, Murakawa M, et al. Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment. Am J Kidney Dis. 1997;29:86-90.
8. Satoh K. Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research. J Gastroenterol. 2002;37:34-38.
9. Miwa H, Nagahara A, Sato K, et al. Efficacy of one week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population. J Gastroenterol Hepatol. 1999;14:317-321.
10. Miwa H, Ohkura R, Murai T, et al. Effectiveness of omeprazole- amoxicillin-clarithromycin (OAC) therapy for Helicobacter pylori infection in a Japanese population. Helicobacter. 1998;3:132-138.
11. Miwa H, Ohkura R, Murai T, et al. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole. Aliment Pharmacol Ther. 1999;13:741-746.
12. Tsukada K, Miyazaki T, Katoh H, et al. Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in hemodialysis patients. Scand J Gastroenterol. 2002;37:1265-1268.
13. Tamura H, Tokushima H, Murakawa M, et al. Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment. Am J Kidney Dis. 1997;29:86-90.
14. Davey PG. The pharmacokinetics of clarithromycin and its 14-OH metabolite. J Hosp Infect. 1991;19:29-37.
15. Humbert G, Spyker DA, Fillastre JP, Leroy A. Pharmacokinetics of amoxicillin: Dosage nomogram for patients with impaired renal function. Antimicrob Agents Chemother. 1979;15:28-33.
16. Milito G, Taccone-Gallucci M, Brancaleone C, et al. Assessment of the upper gastrointestinal tract in hemodialysis patients awaiting renal transplantation. Am J Gastroenterol. 1983;78:328-331.
17. Schlemper RJ, van der Werf SD, Vandenbroucke JP, Biemond I, Lamers CB. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. Scand J Gastroenterol. Suppl. 1993;200:33-41.
18. Loffeld RJ, Peltenburg HG, vd Oever H, Stobberingh E. Prevalence of Helicobacter pylori antibodies in patients on chronic intermittent hemodialysis. Nephron. 1991;59:250-253.
19. Jaspersen D, Fassbinder W, Heinkele P, et al. Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function. J Gastroenterol. 1995;30:585-588.
20. Luzza F, Imeneo M, Maletta M, et al. Helicobacter pylorispecific IgG in chronic hemodialysis patients: relationship of hypergastrinemia to positive serology. Nephrol Dial Transplant. 1996;11:120-124.
21. Abu Farsakh NA, Roweily E, Rababaa M, Butchoun R. Brief report: evaluation of the upper gastrointestinal tract in uraemic patients undergoing hemodialysis. Nephrol Dial Transplant. 1996;11:847-850.
22. Ozgur O, Boyacioglu S, Ozdogan M, Gur G, Telatar H, Haberal M. Helicobacter pylori infection in hemodialysis patients and renal transplant recipients. Nephrol Dial Transplant. 1997;12:289-291.
23. Munoz de Bustillo E, Sanchez Tomero JA, Sanz JC, et al. Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients. Nephron. 1998;79:55-60.
24. Yildiz A, Besisik F, Akkaya V, et al. Helicobacter pylori antibodies in hemodialysis patients and renal transplant recipients. Clin Transplant. 1999;13:13-16.
25. Huang JJ, Huang CJ, Ruaan MK, Chen KW, Yen TS, Sheu BS. Diagnostic efficacy of (13)C-urea breath test for Helicobacter pylori infection in hemodialysis patients. Am J Kidney Dis. 2000;36:124-129.
26. Wang YL, Sheu BS, Huang JJ, Yang HB. Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients. Am J Kidney Dis. 2001;38:98-103.
27. Nakajima F, Sakaguchi M, Amemoto K, et al. Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol. 2002;22:468-472.
28. Nakajima F, Sakaguchi M, Oka H, et al. Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology (Carlton). 2004;9:73-76.
29. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760-766.
30. Gladziwa U, Haase G, Handt S, et al. Prevalence of Helicobacter pylori in patients with chronic renal failure. Nephrol Dial Transport. 1993;8:301-306.
31. Lieber CS, Lefèvre A. Ammonia as a source of gastric hypoacidity in patients with uremia. J Clin Invest. 1959;38:1271-1277.
32. Giachino G, Sallio-Bruno F, Chiappero F, et al. Helicobacter pylori in patients unfergoing periodic hemodialysis. Minerva Urol Nefrol. 1994;46:213-215.
33. Huang J, Hunt RH. The importance of clarithromycin dose in the management of Helicobacter pylori infection: a metaanalysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxicillin or metronidazole. Aliment Pharmacol Ther. 1999;13:719-729.
34. Humbert G, Spyker DA, Fillastre JP, Leroy A. Pharmacokinetics of amoxicillin: Dosage nomogram for patients with impaired renal function. Antimicrob Agents Chemother. 1979;15: 28-33.
35. Jones RH, Cundy T, Bullock R, et al. Concentrations of amoxicillin in serum and dialysate of uremic patients undergoing peritoneal dialysis. J Infect. 1979;1:235-242.
36. Miwa H, Murai T, Sato K, et al. Comparison of the efficacy of 400 mg and 800 mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population. J Gastroenterol. 2000;35:536-539.